CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer
CVS Health (NYSE: CVS) has announced key leadership changes, with Brian Newman appointed as executive vice president and CFO designate effective April 21, succeeding Tom Cowhey who will transition to a strategic advisor role. Additionally, Dr. Amy Compton-Phillips joins as executive vice president and chief medical officer effective May 19.
Based on year-to-date results through February, CVS expects to meet or exceed its previously issued guidance for full year 2025. Newman brings experience from UPS where he served as CFO, and previously spent 26 years at PepsiCo in various finance leadership roles. Dr. Compton-Phillips joins from Press Ganey and has extensive experience in healthcare operations and improvement programs, including roles at Providence Health & Services and Kaiser Permanente.
CVS Health (NYSE: CVS) ha annunciato importanti cambiamenti nella leadership, con Brian Newman nominato vicepresidente esecutivo e CFO designato a partire dal 21 aprile, succedendo a Tom Cowhey, che passerà a un ruolo di consulente strategico. Inoltre, Dr. Amy Compton-Phillips entra come vicepresidente esecutivo e chief medical officer a partire dal 19 maggio.
In base ai risultati dall'inizio dell'anno fino a febbraio, CVS prevede di rispettare o superare le previsioni precedentemente emesse per l'intero anno 2025. Newman porta con sé un'esperienza da UPS, dove ha ricoperto il ruolo di CFO, e ha trascorso in precedenza 26 anni in PepsiCo in vari ruoli di leadership finanziaria. Il Dr. Compton-Phillips proviene da Press Ganey e ha una vasta esperienza nelle operazioni sanitarie e nei programmi di miglioramento, inclusi ruoli presso Providence Health & Services e Kaiser Permanente.
CVS Health (NYSE: CVS) ha anunciado cambios clave en el liderazgo, con Brian Newman nombrado vicepresidente ejecutivo y CFO designado a partir del 21 de abril, sucediendo a Tom Cowhey, quien pasará a un rol de asesor estratégico. Además, Dr. Amy Compton-Phillips se une como vicepresidenta ejecutiva y directora médica a partir del 19 de mayo.
Basado en los resultados acumulados hasta febrero, CVS espera cumplir o superar su guía previamente emitida para el año completo 2025. Newman aporta experiencia de UPS, donde se desempeñó como CFO, y previamente pasó 26 años en PepsiCo en varios roles de liderazgo financiero. El Dr. Compton-Phillips se une de Press Ganey y tiene una amplia experiencia en operaciones de atención médica y programas de mejora, incluidos roles en Providence Health & Services y Kaiser Permanente.
CVS Health (NYSE: CVS)는 주요 리더십 변화를 발표했으며, Brian Newman이 4월 21일부터 부사장 겸 CFO로 임명되어 Tom Cowhey의 뒤를 잇게 됩니다. Cowhey는 전략적 고문 역할로 전환할 예정입니다. 또한, Dr. Amy Compton-Phillips가 5월 19일부터 부사장 겸 최고 의료 책임자로 합류합니다.
2월까지의 연간 누적 결과를 기반으로 CVS는 2025년 전체 연도에 대한 이전에 발표한 가이드를 준수하거나 초과할 것으로 예상하고 있습니다. Newman은 UPS에서 CFO로 근무한 경험을 가지고 있으며, 이전에는 PepsiCo에서 26년 동안 다양한 재무 리더십 역할을 수행했습니다. Compton-Phillips 박사는 Press Ganey에서 합류하며, Providence Health & Services 및 Kaiser Permanente에서의 역할을 포함하여 의료 운영 및 개선 프로그램에 대한 광범위한 경험을 가지고 있습니다.
CVS Health (NYSE: CVS) a annoncé des changements clés dans sa direction, avec Brian Newman nommé vice-président exécutif et CFO désigné à compter du 21 avril, succédant à Tom Cowhey qui passera à un rôle de conseiller stratégique. De plus, Dr. Amy Compton-Phillips rejoint l'entreprise en tant que vice-présidente exécutive et directrice médicale à compter du 19 mai.
Sur la base des résultats cumulés jusqu'en février, CVS s'attend à respecter ou à dépasser les prévisions précédemment émises pour l'année complète 2025. Newman apporte une expérience d'UPS, où il a été CFO, et a précédemment passé 26 ans chez PepsiCo dans divers rôles de leadership financier. Le Dr Compton-Phillips vient de Press Ganey et possède une vaste expérience dans les opérations de santé et les programmes d'amélioration, y compris des rôles chez Providence Health & Services et Kaiser Permanente.
CVS Health (NYSE: CVS) hat wichtige Veränderungen in der Unternehmensführung angekündigt, wobei Brian Newman ab dem 21. April zum Executive Vice President und designierten CFO ernannt wird, um Tom Cowhey nachzufolgen, der in eine strategische Beraterrolle wechseln wird. Darüber hinaus tritt Dr. Amy Compton-Phillips am 19. Mai als Executive Vice President und Chief Medical Officer bei.
Basierend auf den bis Februar erzielten Ergebnissen erwartet CVS, die zuvor herausgegebene Prognose für das gesamte Jahr 2025 zu erfüllen oder zu übertreffen. Newman bringt Erfahrung von UPS mit, wo er als CFO tätig war, und hat zuvor 26 Jahre bei PepsiCo in verschiedenen Führungspositionen im Finanzbereich gearbeitet. Dr. Compton-Phillips kommt von Press Ganey und hat umfangreiche Erfahrung in der Gesundheitsversorgung und in Verbesserungsprogrammen, einschließlich Rollen bei Providence Health & Services und Kaiser Permanente.
- Company expects to meet or exceed full year 2025 guidance
- New CFO brings extensive financial leadership experience from UPS and PepsiCo
- New CMO brings significant healthcare operations expertise from Press Ganey and Providence Health
- Financial closing procedures for Q1 2025 not complete, results may change
- Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.
- Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.
Based on year-to-date results through February, the Company currently expects financial results will meet or exceed its previously issued guidance for full year 2025. Our financial closing procedures for the first quarter of 2025 are not yet complete and, as a result, expected results for the full year may change due to such financial closing procedures, final adjustments, management's review of results, and other developments that may arise between now and the time our financial results for the first quarter of 2025 are finalized.
"As I continue to build out my leadership team, I am confident that Brian and Amy will help us continue the momentum we have built over the past several months as we execute on our strategy to deliver better health care to the 185 million Americans we are privileged to serve," said Joyner. "Their collective and individual experience and expertise are well suited to CVS Health and we welcome them both to our leadership team.
"I am personally grateful for the leadership Tom has shown in his time at CVS Health, and before that, Aetna. He stepped up during a challenging year, and helped position our enterprise for long-term growth opportunities. I wish him all the best in the future."
"It is an honor to join CVS Health, its leadership team, and the Finance organization at such an important time in health care," said Newman. "I am confident in our continued success and growth potential, and I look forward to putting my experience to work as we help our clients, customers, and colleagues succeed."
"As a clinician, I see the best our health care system can do, and as an administrator, I have seen the challenges that stop us from doing our best all the time," said Dr. Compton-Phillips. "CVS Health has every opportunity to deliver simply better health, and that starts with the patient-medical professional relationship. I am committed to making sure we do all we can to improve the experience and outcome of every person we serve."
Brian Newman named executive vice president and chief financial officer designate
Newman was most recently executive vice president and chief financial officer of United Parcel Service. In his nearly five years of leadership, he delivered results that supported employees, customers, and communities, in particular helping lead the company through COVID-19 pandemic.
Before joining UPS, he spent 26 years with PepsiCo and served in finance leadership roles across
Amy Compton-Phillips, M.D., named executive vice president and chief medical officer
Dr. Compton-Phillips was most recently chief physician executive of Press Ganey, a health care performance improvement company. She has an extensive background in directing patient care programs and leading health care organizations to broad-based improvements. Prior to Press Ganey, Dr. Compton-Phillips was the president and chief clinical officer at Providence Health & Services, a health care system, responsible for clinical operations and care including improving health, care, and value outcomes delivered by the system's hospitals, clinics, and caregivers. From 1985 to 2007, she held positions of increasing responsibility at Kaiser Permanente.
Dr. Compton-Phillips earned her bachelor's degree from Johns Hopkins University and her medical degree from the University of Maryland School of Medicine. She is a board-certified internist.
About CVS Health
CVS Health® is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2024, the Company had more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 90 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 36 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Information Regarding Forward Looking Statements
This press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of the Company. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in the Company's Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in the Company's most recently filed Annual Report on Form 10-K.
You are cautioned not to place undue reliance on the Company's forward-looking statements. The Company's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance and are applicable only as of the dates of such statements. The Company does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.
Media contact
Ethan Slavin
860-273-6095
Ethan.Slavin@CVSHealth.com
Investor contact
Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-announces-chief-financial-officer-transition-plan-appoints-chief-medical-officer-302422612.html
SOURCE CVS Health
FAQ
When will Brian Newman start as CVS Health's new CFO?
What is CVS Health's financial outlook for 2025?
Who is replacing Tom Cowhey as CVS Health's CFO?
When will Dr. Amy Compton-Phillips join CVS Health as chief medical officer?
What is Tom Cowhey's new role at CVS Health?
